Shots:

• The JV leverages the expertise of three companies that includes Wilson Wolf’s G-Rex technology- BioTechne’s proteins- reagents- media- and gene-editing technologies and Fresenius Kabi’s Lovo cell processing system washes- concentrates and harvests cells
• The JV focus on providing scalable manufacturing technologies and processes required to develop and commercialize new cell and gene therapies. All the three partners equally owned the JV
• Wilson’s G-Rex technology is designed as a scalable and practical platform for the generation of personalized cell therapies- Biotechne’s technology used to activate- reprogram- and stimulate cell growth while Fresenius Kabi’s Lovo cell processing system required to develop and commercialize cell and gene therapies

Click here ­to­ read full press release/ article | Ref: Wilson wolf | Image: Pro Expo